Devarajan demonstrated (in the four phases of experimental AKI: initiation, extension, maintenance, and recovery) that increased IL-18 levels appeared to occur in the second phase, thus responding less rapidly than NGAL levels, which were elevated in the initiation phase7. Here, LCN2 is linked to acute kidney injury.